3Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process.Gastroenterology 2006; 130:1377-1390 被引量：1
4Smith RC,Greenbaum DS,Vancouver JB,Henry RC,Reinhart MA,Greenbaum RB,Dean HA,Mayle JE.Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome.Gastroenterology 1990; 98:293-301 被引量：1
5Drossman DA,Creed FH,Olden KW,Svedlund J,Toner BB,Whitehead WE.Psychosocial aspects of the functional gastrointestinal disorders.Gut 1999;45 Suppl 2:Ⅱ25-30 被引量：1
6Lydiard RB,Falsetti SA.Experience with anxiety and depression treatment studies:implications for designing irritable bowel syndrome clinical trials.Am J Med 1999; 107:65S-73S 被引量：1
7Heymann-Monnikes I,Arnold R,Florin I,Herda C,Melfsen S,Monnikes H.The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.Am J Gastroenterol 2000; 95:981-994 被引量：1
8Church MK,Clough GF.Human skin mast cells:in vitro and in vivo studies.Ann Allergy Asthma Immunol 1999; 83:471-475 被引量：1
9McKay DM,Bienenstock J.The interaction between mast cells and nerves in the gastrointestinal tract.Immunol Today 1994; 15:533-538 被引量：1
10Bradding P,Holgate ST.Immunopathology and human mast cell cytokines.Crit Rev Oncol Hematol 1999; 31:119-133 被引量：1
